Browse by Author

Article

Watkins, Harriet A.; Rathbone, Dan L.; Barwell, James; Hay, Debbie L. and Poyner, David R (2013). Structure-activity relationships for α-calcitonin gene-related peptide. British Journal of Pharmacology, 170 (7), pp. 1308-1322.

Badarau, Eduard; Mongeot, Alexandre; Collighan, Russell; Rathbone, Dan and Griffin, Martin (2013). Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors. European Journal of Medicinal Chemistry, 66 , pp. 526-530.

Daneshpour, Nooshin; Collighan, Russell; Perrie, Yvonne; Lambert, Peter; Rathbone, Dan; Lowry, Deborah and Griffin, Martin (2013). Indwelling catheters and medical implants with FXIIIa inhibitors:a novel approach to the treatment of catheter and medical device-related infections. European Journal of Pharmaceutics and Biopharmaceutics, 83 (1), 106–113.

Wang, Zhuo; Collighan, Russell; Pytel, Kamila; Rathbone, Dan L; Li, Xiaoling and Griffin, Martin (2012). Characterization of heparin-binding site of tissue transglutaminase:its importance in cell surface targeting, matrix deposition, and cell signaling. Journal of Biological Chemistry, 287 (16), pp. 13063-13083.

Qi, Tao; Simms, John; Bailey, Richard J.; Wheatley, Mark; L. Rathbone, Daniel; Hay, Debbie L. and Poyner, David R (2010). Structure-function analysis of RAMP1-RAMP3 chimeras. Biochemistry, 49 (3), pp. 522-531.

Bailey, Richard J.; Bradley, Joshua W.I.; Poyner, David R; L. Rathbone, Daniel and Hay, Debbie L. (2010). Functional characterization of two human receptor activity-modifying protein 3 variants. Peptides, 31 (4), pp. 579-584.

Costello, Cait; Karpanen, Tarja; Lambert, Peter A.; Mistry, Preena; Parker, Katy J.; Rathbone, Daniel L.; Ren, Jiangmeng; Wheeldon, Laura and Worthington, Tony (2008). Thiosemicarbazones active against Clostridium difficile. Bioorganic and Medicinal Chemistry Letters, 18 (5), pp. 1708-1711.

Coleman, Michael D.; Aerry, R.; Wanogho, E.; Khan, N.B.; Lambert, Peter A. and Rathbone, Daniel L. (2006). Effects of glutathione and N-acetyl cysteine on the antimycobacterial efficacy of isoniazid on Mycobacterium fortuitum in vitro. Journal of Chemotherapy, 18 (6), pp. 665-666.

Rathbone, Daniel L.; Parker, Katy J.; Coleman, Michael D.; Lambert, Peter A. and Billington, David C. (2006). Discovery of a potent phenolic N1-benzylidene- pyridinecarboxamidrazone selective against Gram-positive bacteria. Bioorganic and Medicinal Chemistry Letters, 16 (4), pp. 879-883.

Rathbone, Daniel L.; Ali, Aisha; Antonaki, Polyxeni and Cheek, Sarah (2005). Towards a polymeric binding mimic for cytochrome CYP2D6. Biosensors and Bioelectronics, 20 (11), pp. 2353-2363.

Rathbone, Daniel L. and Bains, Ajeet (2005). Tools for fluorescent molecularly imprinted polymers. Biosensors and Bioelectronics, 20 (7), pp. 1438-1442.

Coleman, Michael D.; Khan, Nazish; Welton, Graham; Lambert, Peter A.; Tims, Katy J. and Rathbone, Daniel L. (2004). Effects of glutathione, N-acetyl-cysteine, α-lipoic acid and dihydrolipoic acid on the cytotoxicity of a 2-pyridylcarboxamidrazone antimycobacterial agent in human mononuclear leucocytes in vitro. Environmental Toxicology and Pharmacology, 17 (3), pp. 143-148.

Simpson, Julie; Forrester, Rebecca; Tisdale, Michael J.; Billington, David C. and Rathbone, Daniel L. (2003). Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic and Medicinal Chemistry Letters, 13 (15), pp. 2435-2439.

Gokhale, Nikhil H.; Padhye, Subhash B.; Billington, David C.; Rathbone, Daniel L.; Croft, Simon L.; Kendrick, Howard D.; Anson, Christopher E. and Powell, Annie K. (2003). Synthesis and characterization of copper(II) complexes of pyridine-2-carboxamidrazones as potent antimalarial agents. Inorganica Chimica Acta, 349 , pp. 23-29.

Coleman, MD; Tims, Katy J. and Rathbone, Daniel L. (2003). The use of computational QSAR analysis in the toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds. Environmental Toxicology and Pharmacology, 14 (1-2), pp. 33-42.

Thanh, Nguyen Thi Kim; Rathbone, Daniel L.; Billington, David C. and Hartell, Nicholas A. (2002). Selective recognition of cyclic GMP using a fluorescence-based molecularly imprinted polymer. Analytical letters, 35 (15), pp. 2499-2509.

Rathbone, Daniel L. and Ge, Ye (2001). Selectivity of response in fluorescent polymers imprinted with N1-benzylidene pyridine-2-carboxamidrazones. Analytica Chimica Acta, 435 (1), pp. 129-136.

Coleman, Michael D.; Rathbone, Daniel L.; Chima, Rajinda; Lambert, Peter A. and Billington, David C. (2001). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology, 9 (3), pp. 99-102.

Badarau, Eduard; Wang, Zhuo; Rathbone, Dan L.; Costanzi, Andrea; Thibault, Thomas; Murdoch, Colin E.; El Alaoui, Said; Bartkeviciute, Milda and Griffin, Martin Development of potent and selective tissue transglutaminase inhibitors:their effect on TG2 function and application in pathological conditions. Chemistry and Biology, 22 (10), pp. 1347-1361.

Griffin, Martin; Mongeot, Alexandre; Collighan, Russell; Saint, Robert E.; Jones, Richard A.; Coutts, Ian G.C. and Rathbone, Daniel L. Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorganic and Medicinal Chemistry Letters, 18 (20), pp. 5559-5562.

Griffin, Martin; Wang, Zhuo; Thibault, Thomas; Murdoch, Colin and Rathbone, Daniel TG2: a credible therapeutic target in fibrotic diseasedue to its multifunctional roles. Amino Acids, 47 (8), p. 1629.

Hay, Debbie L.; Harris, Paul W.R.; Kowalczyk, Renata; Brimble, Margaret A.; Rathbone, Dan L; Barwell, James; Conner, Alex C. and Poyner, David R. Structure-activity relationships of the N-terminus of calcitonin gene-related peptide:key roles of alanine-5 and threonine-6 in receptor activation. British Journal of Pharmacology, 171 (2), pp. 415-426.

Rathbone, Daniel L. Molecularly imprinted polymers in the drug discovery process. Advanced Drug Delivery Reviews, 57 (12), pp. 1854-1874.